| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1528-1157.2002.365011.X |
| P698 | PubMed publication ID | 12027907 |
| P2093 | author name string | Alejandro A Nava-Ocampo | |
| Angélica M Bello-Ramírez | |||
| Blanca Y Carreón-Garabito | |||
| P2860 | cites work | Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity | Q28324498 |
| Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid | Q28341501 | ||
| Side effects of valproate | Q30461785 | ||
| Hematologic toxicity of sodium valproate | Q33331641 | ||
| Multiorgan system failure caused by valproic acid toxicity | Q42055769 | ||
| Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy | Q42249084 | ||
| Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies | Q43405786 | ||
| Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrier | Q43770015 | ||
| Valproate metabolites in the rat brain--regional distribution in various brain areas | Q48158853 | ||
| Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design | Q48208266 | ||
| Molecular factors influencing drug transfer across the blood-brain barrier | Q48534771 | ||
| Beta-oxidation of valproate. II. Effects of fasting, glucose, and clofibrate in rats. | Q51618721 | ||
| Beta-oxidation of valproic acid. I. Effects of fasting and glucose in humans. | Q51618724 | ||
| Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. | Q53023073 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 475-481 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Do structural properties explain the anticonvulsant activity of valproate metabolites? A QSAR analysis | |
| P478 | volume | 43 |
| Q45153296 | A QSAR analysis of toxicity of Aconitum alkaloids |
| Q54353652 | A QSAR analysis to explain the analgesic properties of Aconitum alkaloids. |
| Q44751499 | Lipophilicity affects the pharmacokinetics and toxicity of local anaesthetic agents administered by caudal block |
| Q38258233 | QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity. |
| Q53767428 | QSPR Study of Valproic Acid and Its Functionalized Derivatives. |
| Q44831593 | The local anesthetic activity of Aconitum alkaloids can be explained by their structural properties: a QSAR analysis |
Search more.